Cell-bound Complement Activation Products in Combination with Low Complement C3 or C4 Have Superior Diagnostic Performance in Systemic Lupus Erythematosus

被引:0
|
作者
Narain, Sonali [1 ]
Wallace, Daniel [2 ]
Putterman, Chaim [3 ]
Arriens, Cristina [4 ]
Askanase, Anca [5 ]
Kalunian, Kenneth [6 ]
Collins, Christopher [7 ]
Saxena, Amit [8 ]
Massarotti, Elena [9 ]
Alexander, Roberta [10 ]
Ibarra, Claudia [10 ]
O'Malley, Tyler [11 ]
Conklin, John [10 ]
Ramsey-Goldman, Rosalind [12 ]
Ahearn, Joseph [13 ]
Manzi, Susan [13 ]
Weinstein, Arthur [10 ]
Dervieux, Thierry [10 ]
机构
[1] Northwell Hlth, Great Neck, NY USA
[2] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Albert Einstein Coll Med, New York, NY USA
[4] Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Oklahoma City, OK USA
[5] Columbia Univ, New York, NY USA
[6] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[7] MedStar Washington Hosp Ctr, Dept Rheumatol, Washington, DC USA
[8] NYU, Sch Med, New York, NY USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[10] Exagen, Vista, CA USA
[11] Exagen, Oceanside, CA USA
[12] Northwestern Univ, Chicago, IL 60611 USA
[13] Allegheny Hlth Network, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2887
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Cell bound complement activation products alone and in combination with low serum complement C3 or C4 have superior diagnostic performance in systemic lupus erythematosus
    Weinstein, Arthur
    Wallace, Daniel J.
    Putterman, Chaim
    Arriens, Cristina
    Askanase, Anca
    Kalunian, Kenneth C.
    Collins, Christopher E.
    Saxena, Amit
    Massarotti, Elena M.
    Alexander, Roberta Vezza
    Ibarra, Claudia
    Chatham, Winn
    Ramsey-Goldman, Rosalind
    Narain, Sonali
    Chandra, Tarun
    Ahearn, Joseph
    Manzi, Susan
    Dervieux, Thierry
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [2] Cell-bound complement activation products are superior to serum complement C3 and C4 levels to detect complement activation in systemic lupus erythematosus: comment on the article by Aringer et al Reply
    Aringer, Martin
    Costenbader, Karen H.
    Doerner, Thomas
    Johnson, Sindhu R.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (05) : 860 - 861
  • [3] Cell Bound Complement Activation Products Have Higher Sensitivity Than Serum C3 and C4 Levels in Systemic Lupus Erythematosus.
    Ramsey-Goldman, Rosalind
    Furie, Richard
    Putterman, Chaim
    Askanase, Anka
    Buyon, Jill P.
    Kalunian, Kenneth
    Chatham, W. Winn
    Massarotti, E.
    Kirou, Kyriakos A.
    Weinstein, A.
    Chitkara, Puja
    Manzi, Susan
    Ahearn, Joe
    Wolover, Leilani
    Conklin, John
    O'Malley, Tyler
    Ibarra, Claudia
    Barken, Derren
    Dervieux, Thierry
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S846 - S847
  • [4] Measurement of Cell-Bound Complement Activation Products Enhances Diagnostic Performance in Systemic Lupus Erythematosus
    Kalunian, Kenneth C.
    Chatham, W. Winn
    Massarotti, Elena M.
    Reyes-Thomas, Joyce
    Harris, Cole
    Furie, Richard A.
    Chitkara, Puja
    Putterman, Chaim
    Gross, Rachel L.
    Somers, Emily C.
    Kirou, Kyriakos A.
    Ramsey-Goldman, Rosalind
    Hsieh, Christine
    Buyon, Jill P.
    Dervieux, Thierry
    Weinstein, Arthur
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4040 - 4047
  • [5] Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus
    Li, Hejun
    Lin, Shunping
    Yang, Shangchih
    Chen, Ling
    Zheng, Xiangxiong
    CLINICAL RHEUMATOLOGY, 2015, 34 (03) : 471 - 477
  • [6] Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus
    Hejun Li
    Shunping Lin
    Shangchih Yang
    Ling Chen
    Xiangxiong Zheng
    Clinical Rheumatology, 2015, 34 : 471 - 477
  • [7] B CELL-BOUND COMPLEMENT ACTIVATION PRODUCTS IN THE DIAGNOSIS AND MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Beckmann, J.
    Bartholomae, N.
    Venhoff, N.
    Henneke, P.
    Janda, A.
    Salzer, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 785 - 786
  • [8] Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
    Garabet, L.
    Gilboe, I. -M.
    Mowinckel, M. -C.
    Jacobsen, A. F.
    Mollnes, T. E.
    Sandset, P. M.
    Jacobsen, E. -M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2016, 84 (02) : 95 - 99
  • [9] THIRD COMPONENT OF COMPLEMENT (C3) AND FOURTH COMPONENT OF COMPLEMENT (C4) IN DISCOID AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    RISUM, G
    DERMATOLOGICA, 1973, 147 (06): : 381 - 390
  • [10] Probable systemic lupus erythematosus with cell-bound complement activation products (CB-CAPS)
    Lamichhane, D.
    Weinstein, A.
    LUPUS, 2016, 25 (09) : 1050 - 1053